Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Landos Biopharma, Inc. LABP
$0.30
+$0 (0.92%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
9285066.00000000
-
week52high
1.37
-
week52low
0.21
-
Revenue
0
-
P/E TTM
0
-
Beta
-1.15723700
-
EPS
-0.96000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and eosinophilic esophagitis; NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1 (NOD-like), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and LABP-104, an orally-active and systemically bioavailable small molecule therapeutic candidate that targets LANCL2 agonist for the treatment of systemic lupus erythematosus and rheumatoid arthritis (RA). Its preclinical candidates in development include LABP-66 is an oral and small molecule NOD-like pathway agonist for the treatment of multiple sclerosis and Alzheimer's disease; LABP-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and RA; LABP-73, an oral and small molecule NLRX1 pathway agonist in development for the treatment of asthma and chronic obstructive pulmonary disease; and LABP-111, an oral and small molecule LANCL2 pathway agonist for the treatment of nonalcoholic steatohepatitis and type 1 diabetes. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| SVB Leerink | Market Perform | Market Perform | 12 авг 2022 г. |
| Raymond James | Market Perform | Outperform | 12 авг 2022 г. |
| Jefferies | Hold | Buy | 12 апр 2022 г. |
| Raymond James | Outperform | Outperform | 25 мар 2022 г. |
| JP Morgan | Neutral | Neutral | 03 янв 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 11 ноя 2022 г. |
| Jefferies | Underperform | Hold | 06 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | A | 3636363 | 3636363 | 10 янв 2023 г. |
| PERCEPTIVE ADVISORS LLC | A | 27272727 | 27272727 | 10 янв 2023 г. |
| RTW INVESTMENTS, LP | D | 3975722 | 300000 | 23 сент 2022 г. |
| Cataldi Fabio | A | 400000 | 400000 | 05 сент 2022 г. |
| Bassaganya-Riera Josep | A | 500000 | 500000 | 05 авг 2022 г. |
| Bassaganya-Riera Josep | D | 3494208 | 500000 | 05 авг 2022 г. |
| Oakes Gregory | A | 1677251 | 1677251 | 20 июн 2022 г. |
| MAYLEBEN TIMOTHY M | A | 18000 | 18000 | 17 июн 2022 г. |
| Callori Fred | A | 18000 | 18000 | 07 июн 2022 г. |
| Garabedian Christopher Nishan | A | 18000 | 18000 | 07 июн 2022 г. |
Новостная лента
3 Top Biotech Penny Stocks Under $3 To Watch Right Now
PennyStocks
19 дек 2022 г. в 13:00
Biotech penny stocks to watch right now. The post 3 Top Biotech Penny Stocks Under $3 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
5 Biotech Stocks Set to Outpace Q1 Earnings Estimates
Zacks Investment Research
11 мая 2022 г. в 09:02
Let us take a look at some drug/biotech stocks, ANGN, APLT, BOLT, IKNA and LABP, which are poised to beat on first-quarter earnings.